The Biden administration secured the procurement of 20 million treatment courses of Paxlovid, Pfizer’s antiviral Covid-19 tablet.
Paxlovid is a five-day antiviral treatment that combines a novel antiviral medicine called nirmatrelvir with an older one called ritonavir, and is taken as three pills twice a day for five days.
The antiviral pill has been approved for use in high-risk persons 12 and older, including those with diabetes, cardiovascular disease, or obesity, under an FDA emergency use authorization.
According to the White House, the Biden administration would cooperate with Pfizer to speed up production and delivery of the new drug to pharmacies across the country, with pharmacies able to order 100,000 courses every quarter while demand and adoption are assessed.
The Biden Administration also announced a test-to-treat effort that includes “one-stop” locations where patients can get free Covid-19 testing and, if positive, can get free antiviral drugs right away.
“For many Americans, pharmacies are the most common and convenient place to pick up their prescriptions and receive other forms of health care.” the White House said.
© Fourth Estate
® — All Rights Reserved.
This material may not be published, broadcast, rewritten or redistributed.